Stockscreener 앱 받기
11.68
0.26%
-0.03
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
Avoiding Lag: Real-Time Signals in (BNTC) Movement - Stock Traders Daily
Aug Setups: Will Benitec Biopharma Inc face regulatory challengesTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn
Aug Gainers: How supply chain issues affect Benitec Biopharma Inc stockEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ
Citizens reiterates Market Outperform rating on Benitec BioPharma stock By Investing.com - Investing.com Canada
Market Wrap: What is the PEG ratio of Benitec Biopharma Inc2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target - Investing.com India
Benitec Biopharma (BNTC) Reports Promising Results from BB-301 S - GuruFocus
Benitec Biopharma Inc. Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - marketscreener.com
Can Benitec Biopharma Inc. stock double in next 5 years2025 Fundamental Recap & AI Forecasted Entry and Exit Points - Улправда
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Is Benitec Biopharma Inc. stock a buy before product launches2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда
Why Benitec Biopharma Inc. stock could be next big winnerStraddle and Strangle Trades & Superior Capital Trading Plans - bollywoodhelpline.com
Published on: 2026-01-09 06:38:29 - Улправда
Is Benitec Biopharma Inc. stock a buy on dipsGap Up & Verified Swing Trading Watchlist - Улправда
Benitec Biopharma Inc. (BNTC) Investor Outlook: Exploring a 105.93% Potential Upside in Genetic Medicine - DirectorsTalk Interviews
Suvretta Capital Management, LLC Acquires Additional Shares in B - GuruFocus
Discipline and Rules-Based Execution in BNTC Response - Stock Traders Daily
Tahmar Enterprises Limited (516032) Announces Strategic ShiftReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 16,836 Shares - Defense World
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m - Investing.com India
Suvretta Capital Management, L Purchases 77,387 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m By Investing.com - Investing.com South Africa
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect? - Eastern Progress
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Purchases 50,000 Shares of Stock - MarketBeat
Wall Street analysts predict an 87.48% upside in Benitec Biopharma (BNTC): Here's what you should know - MSN
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Purchases 10,215 Shares of Stock - Defense World
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 By Investing.com - Investing.com UK
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 16,384 Shares - MarketBeat
Suvretta Capital Management, L Acquires 10,215 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Acquires 19,542 Shares of Stock - MarketBeat
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 - Investing.com
Why Benitec Biopharma Inc. stock attracts global investorsQuarterly Market Review & Community Verified Trade Alerts - Улправда
Benitec Biopharma Earnings Notes - Trefis
Can Benitec Biopharma Inc. stock outperform in 2025 bull market - Улправда
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting - MSN
Will Benitec Biopharma Inc. stock attract more institutional investorsWeekly Investment Report & Smart Investment Allocation Insights - DonanımHaber
4.73%
0.92%
자본화:
|
볼륨(24시간):